Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Telehealth company Hims Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The ad also marks a pivot for the telehealth company colloquially known as Hims, which rose to prominence just under a decade ago, slickly marketing hair-loss treatments and erectile-dysfunction ...

If you buy something, we may earn an affiliate commission. Nobody really looks forward to reading a Hims review. But hair loss comes for us all eventually—no matter how much you deny it or ...